A randomized comparison of peripheral blood hematopoietic progenitor cell level of 5/mm3 versus 50/mm3 as a surrogate marker to initiate efficient autologous blood stem cell collection

Journal of Clinical Apheresis

Volumn 22, Issue 5, 2007, Pages 277-282

  Min, Kyoung Kim ^a   Kim, Shin ^a   Jang, Geundoo ^a   Sung, Sook Lee ^a   Sun, Jin Sym ^a   Dae, Ho Lee ^a   Sang, We Kim ^a   Jang, Seongsoo ^a   Chan, Jeong Park ^a   Hyun, Sook Chi ^a   Huh, Jooryung ^a   Suh, Cheolwon ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Autologous; Blood stem cell mobilization; Hematopoietic progenitor cell assay; Transplantation

Indexed keywords

ACICLOVIR; BUSULFAN; CARMUSTINE; CIPROFLOXACIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; MELPHALAN; METHYLPREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB;

ADULT; AGED; APHERESIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE MARKER; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; RANDOMIZED CONTROLLED TRIAL; STEM CELL MOBILIZATION;

ADULT; BLOOD CELL COUNT; BLOOD TRANSFUSION, AUTOLOGOUS; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 35548932871     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20148     Document Type: Article

References (25)

1. Hartmann O, Le Corroller AG, Blaise D, Michon J, Philip I, Norol F, Janvier M, Pico JL, Baranzelli MC, Rubie H, Coze C, Pinna A, Meresse V, Benhamou E. Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial. Ann Intern Med 1997;126:600-607.
2. Siena S, Schiavo R, Pedrazzoli P, Carlo-Stella C. Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. J Clin Oncol 2000;18:1360-1377.
3. To LB, Haylock DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood 1997;89:2233-2258.
4. Pettengell R, Morgenstern GR, Woll PJ, Chang J, Rowlands M, Young R, Radford JA, Scarffe JH, Testa NG, Crowther D. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 1993;82:3770-3777.
5. Ho AD, Gluck S, Germond C, Sinoff C, Dietz G, Maruyama M, Corringham RE. Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocytemacrophage colony-stimulating factor for autologous transplantation in advanced breast cancer. Leukemia 1993;7:1738-1746.
6. Haas R, Moos M, Karcher A, Mohle R, Witt B, Goldschmidt H, Fruhauf S, Flentje M, Wannenmacher M, Hunstein W. Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma. J Clin Oncol 1994;12:1685-1692.
7. Park KU, Kim SH, Suh C, Kim S, Lee SJ, Park JS, Cho HJ, Kim KW, Lee K, Kim HJ, Park J, Joo Min Y, Kim JG, Kim T, Lee JH, Kim SB, Kim SW, Lee KH, Lee JS, Kim WK, Part CJ, Chi HS. Correlation of hematopoietic progenitor cell count determined by the SE-automated hematology analyzer with CD34(+) cell count by flow cytometry in leukapheresis products. Am J Hematol 2001;67:42-47.
8. Takekawa K, Yamane T, Suzuki K, Hino M, Tatsumi N. Identification of hematopoietic stem cells by the SE-9000 automated hematology analyzer in peripheral blood stem cell harvest samples. Acta Haematol 1997;98:54-55.
9. Yu J, Leisenring W, Fritschle W, Heimfeld S, Shulman H, Bensinger WI, Holmberg LA, Rowley SD. Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collection. Bone Marrow Transplant 2000;25: 1157-1164.
10. Peng L, Yang J, Yang H, Peng Z, Xu C, Liu T. Determination of peripheral blood stem cells by the Sysmex SE-9500. Clin Lab Haematol 2001;23:231-236.
11. Lee JL, Kim SB, Lee GW, Ryu MH, Kim EK, Kim S, Kim WK, Lee JS, Park KU, Suh C. Clinical usefulness of the hematopoietic progenitor cell counts in predicting the optimal timing of peripheral blood stem cell harvest. J Korean Med Sci 2003;18:27-35.
12. Suh C, Kim S, Kim SH, Kim EK, Lee JL, Park KU, Park JS, Lee J, Kim MW, Chi HS, Park CJ, Kim SW. Initiation of peripheral blood progenitor cell harvest based on peripheral blood hematopoietic progenitor cell counts enumerated by the Sysmex SE9000. Transfusion 2004;44:1762-1768.
13. Perez-Simon JA, Caballero MD, Corral M, Nieto MJ, Orfao A, Vazquez L, Amigo ML, Berges C, Gonzalez M, Del Canizo C, San Miguel JF. Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation. Transfusion 1998;38:385-391.
14. van der Wall E, Richel DJ, Holtkamp MJ, Slaper-Cortenbach IC, van der Schoot CE, Dalesio O, Nooijen WJ, Schornagel JH, Rodenhuis S. Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size. Ann Oncol 1994;5:795-802.
15. Beguin Y, Baudoux E, Sautois B, Fraipont V, Schaaf-Lafontaine N, Pereira M, Paulus JM, Sondag D, Fillet G. Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells. Transfusion 1998;38:199-208.
16. Dercksen MW, Rodenhuis S, Dirkson MK, Schaasberg WP, Baars JW, van der Wall E, Slaper-Cortenbach IC, Pinedo HM, Von dem Borne AE, van der Schoot CE, Gerritsen WR. Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation. J Clin Oncol 1995; 13:1922-1932.
17. Watts MJ, Sullivan AM, Jamieson E, Pearce R, Fielding A, Devereux S, Goldstone AH, Linch DC. Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma. J Clin Oncol 1997; 15:535-546.
18. Dreger P, Marquardt P, Haferlach T, Jacobs S, Mulverstedt T, Eckstein V, Suttorp M, Loffler H, Muller-Ruchholtz W, Schmitz N. Effective mobilisation of peripheral blood progenitor cells with 'Dexa-BEAM' and G-CSF: timing of harvesting and composition of the leukapheresis product. Br J Cancer 1993;68:950-957.
19. Passos-Coelho JL, Braine HG, Davis JM, Huelskamp AM, Schepers KG, Ohly K, Clarke B, Wright SK, Noga SJ, Davidson NE, Kennedy MJ. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. J Clin Oncol 1995; 13:705-714.
20. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, West W. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995;86:3961-3969.
21. Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L, Cheson B, Crowley J, Barlogie B. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995;85:588-596.
22. Yamane T, Takekawa K, Tatsumi N. Possibility of identification of hematopoietic stem cells using a conventional blood cell counter. Eur J Haematol 1995;55:207-208.
23. Dreger P, Kloss M, Petersen B, Haferlach T, Loffler H, Loeffler M, Schmitz N. Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood 1995;86:3970-3978.
24. Moskowitz CH, Glassman JR, Wuest D, Maslak P, Reich L, Gucciardo A, Coady-Lyons N, Zelenetz AD, Nimer SD. Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma. Clin Cancer Res 1998;4:311-316.
25. Weaver CH, Zhen B, Buckner CD. Treatment of patients with malignant lymphoma with Mini-BEAM reduces the yield of CD34+ peripheral blood stem cells. Bone Marrow Transplant 1998;21:1169-1170.